Deutsche Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.8M | Buy |
|
|||||
|
2025
Q2 | $48.8M | Sell |
|
|||||
|
2025
Q1 | $133M | Buy |
|
|||||
|
2024
Q4 | $110M | Buy |
|
|||||
|
2024
Q3 | $109M | Sell |
|
|||||
|
2024
Q2 | $149M | Sell |
|
|||||
|
2024
Q1 | $204M | Sell |
|
|||||
|
2023
Q4 | $328M | Buy |
|
|||||
|
2023
Q3 | $124M | Sell |
|
|||||
|
2023
Q2 | $173M | Sell |
|
|||||
|
2023
Q1 | $204M | Sell |
|
|||||
|
2022
Q4 | $247M | Buy |
|
|||||
|
2022
Q3 | $188M | Buy |
|
|||||
|
2022
Q2 | $102M | Buy |
|
|||||
|
2022
Q1 | $68.7M | Sell |
|
|||||
|
2021
Q4 | $83.1M | Buy |
|
|||||
|
2021
Q3 | $69M | Sell |
|
|||||
|
2021
Q2 | $98.2M | Buy |
|
|||||
|
2021
Q1 | $85.9M | Buy |
|
|||||
|
2020
Q4 | $92.8M | Sell |
|
|||||
|
2020
Q3 | $104M | Sell |
|
|||||
|
2020
Q2 | $184M | Buy |
|
|||||
|
2020
Q1 | $125M | Buy |
|
|||||
|
2019
Q4 | $110M | Buy |
|
|||||
|
2019
Q3 | $82M | Sell |
|
|||||
|
2019
Q2 | $136M | Buy |
|
|||||
|
2019
Q1 | $124M | Buy |
|
|||||
|
2018
Q4 | $76.5M | Sell |
|
|||||
|
2018
Q3 | $119M | Buy |
|
|||||
|
2018
Q2 | $106M | Sell |
|
|||||
|
2018
Q1 | $101M | Buy |
|
|||||
|
2017
Q4 | $91.9M | Sell |
|
|||||
|
2017
Q3 | $130M | Buy |
|
|||||
|
2017
Q2 | $124M | Buy |
|
|||||
|
2017
Q1 | $117M | Sell |
|
|||||
|
2016
Q4 | $120M | Sell |
|
|||||
|
2016
Q3 | $143M | Buy |
|
|||||
|
2016
Q2 | $107M | Buy |
|
|||||
|
2016
Q1 | $110M | Buy |
|
|||||
|
2015
Q4 | $117M | Sell |
|
|||||
|
2015
Q3 | $128M | Buy |
|
|||||
|
2015
Q2 | $160M | Buy |
|
|||||
|
2015
Q1 | $140M | Sell |
|
|||||
|
2014
Q4 | $104M | Sell |
|
|||||
|
2014
Q3 | $97.3M | Buy |
|
|||||
|
2014
Q2 | $64.2M | Buy |
|
|||||
|
2014
Q1 | $61.8M | Sell |
|
|||||
|
2013
Q4 | $87.9M | Sell |
|
|||||
|
2013
Q3 | $121M | Sell |
|
|||||
|
2013
Q2 | $116M | Buy |
|